Q waves and failed ST resolution: Will intra-myocardial haemorrhage be a concern in reperfusing "late presenting" STEMIs?

International Journal of Cardiology

Volumn 182, Issue C, 2015, Pages 203-210

  Wong, Cheuk Kit ^a   Bucciarelli Ducci, Chiara ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Failed ST resolution; Intra myocardial haemorrhage; Q waves

Indexed keywords

ADVERSE EFFECTS; ANIMAL; ELECTROCARDIOGRAPHY; HEART MUSCLE; HEART MUSCLE REPERFUSION; HEMORRHAGE; HUMAN; MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES;

ANIMALS; ELECTROCARDIOGRAPHY; HEMORRHAGE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM;

EID: 84949117538     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.12.057     Document Type: Review

References (44)

1. L.A. Higginson, F. White, H.A. Heggtveit, T.M. Sanders, C.M. Bloor, J.W. Covell, Determinants of myocardial hemorrhage after coronary reperfusion in the anesthetized dog, Circulation 65 (1982) 62-69.
2. J. Ganame, G.Messalli, S. Dymarkowski, F.E. Rademakers, W. Desmet, F. Van de Werf, J. Bogaert, Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction, Eur. Heart J. 30 (2009) 1440-1449.
3. A.N. Mather, T.A. Fairbairn, N.J. Artis, J.P. Greenwood, S. Plein, Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling, Radiology 261 (2011) 116-126.
4. A.N. Mather, T.A. Fairbairn, S.G. Ball, J.P. Greenwood, S. Plein, Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk, Heart 97 (2010) 453-459.
5. I. Eitel, K. Kubusch, O. Strohm, S. Desch, Y.Mikami, S. de Waha, M. Gutberlet, G. Schuler, M.G. Friedrich, H. Thiele, Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction, Circ. Cardiovasc. Imaging 4 (2011) 354-362.
6. C.K.Wong, S. Leon de la Barra, P. Herbison, Does ST resolution achieved via different reperfusion strategies (fibrinolysis vs percutaneous coronary intervention) have different prognostic meaning in ST-elevation myocardial infarction? A systematic review, Am. Heart J. 160 (2010) 842-848.
7. U. Zeymer, K. Schröder, K. Wegscheider, J. Senges, K.L. Neuhaus, R. Schröder, ST resolution in a single electrocardiographic lead: a simple and accurate predictor of cardiac mortality in patients with fibrinolytic therapy for acute ST-elevation myocardial infarction, Am. Heart J. 149 (2005) 91-97.
8. M.G. McLaughlin, G.W. Stone, E. Aymong, G. Gardner, R. Mehran, A.J. Lansky, C.L. Grines, J.E. Tcheng, D.A. Cox, T. Stuckey, E. Garcia, G. Guagliumi, M. Turco, M.E. Josephson, P. Zimetbaum, Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications Trial. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial, J. Am. Coll. Cardiol. 44 (2004) 1215-1223.
9. C.E. Buller, Y. Fu, K.W. Mahaffey, T.G. Todaro, P. Adams, C.M. Westerhout, H.D. White, A.W. van't Hof, F.J. Van de Werf, G.S. Wagner, C.B. Granger, P.W. Armstrong, ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial, Circulation 118 (2008) 1335-1346.
10. K. Schröder, K. Wegscheider, U. Zeymer, U. Tebbe, R. Schröder, Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction, Lancet 358 (2001) 1479-1486.
11. C.K. Wong, Detecting ST, deviations: does body surface mapping help or have we missed information from lead aVR? Int. J. Cardiol. 152 (2011) 403-407.
12. J. Andrews, I.T. Straznicky, J.K. French, C.L. Green, A.C. Maas, M. Lund, M.W. Krucoff, H.D. White, ST-segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy, Circulation 101 (2000) 2138-2143.
13. C.K. Wong, J.K. French, M.W. Krucoff, W. Gao, P.E. Aylward, H.D. White, Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion, Eur. Heart J. 23 (2002) 1449-1455.
14. P.W. Armstrong, Y. Fu, C.M. Westerhout, M.P. Hudson, K.W. Mahaffey, H.D. White, T.G. Todaro, P.X. Adams, P.E. Aylward, C.B. Granger, Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention, J. Am. Coll. Cardiol. 53 (2009) 1503-1509.
15. H. Siha, D. Das, Y. Fu, Y. Zheng, C.M. Westerhout, R.F. Storey, S. James, L. Wallentin, P.W. Armstrong, Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial, CMAJ 184 (2012) 1135-1142.
16. D.J. Hausenloy, D.M. Yellon, Myocardial ischemia-reperfusion injury: a neglected therapeutic target, J. Clin. Invest. 123 (2013) 92-100.
17. K.C. Wu, CMR of microvascular obstruction and hemorrhage in myocardial infarction, J. Cardiovasc. Magn. Reson. 14 (2012) 68.
18. C. Cannan, I. Eitel, J. Hare, A. Kumar, M. Friedrich, Hemorrhage in the myocardium following infarction, JACC Cardiovasc. Imaging 3 (2010) 665-668.
19. M. Francone, C. Bucciarelli-Ducci, I. Carbone, E. Canali, R. Scardala, F.A. Calabrese, G. Sardella, M. Mancone, C. Catalano, F. Fedele, R. Passariello, J. Bogaert, L. Agati, Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance, J. Am. Coll. Cardiol. 54 (2009) 2145-2153.
20. E.J. van den Bos, T. Baks, A.D. Moelker, W. Kerver, R.J. van Geuns, W.J. van der Giessen, D.J. Duncker, P.A. Wielopolski, Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking? Eur. Heart J. 27 (2006) 1620-1626.
21. L.F. Robbers, E.S. Eerenberg, P.F. Teunissen, M.F. Jansen, M.R. Hollander, A.J. Horrevoets, P. Knaapen, R. Nijveldt, M.W. Heymans, M.M. Levi, A.C. van Rossum, H.W. Niessen, C.B. Marcu, A.M. Beek, N. van Royen, Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage, Eur. Heart J. 34 (2013) 2346-2353.
22. A. Kumar, J.D. Green, J.M. Sykes, P. Ephrat, J.J. Carson, A.J. Mitchell, G. Wisenberg, M.G. Friedrich, Detection and quantification of myocardial reperfusion hemorrhage using T2∗-weighted CMR, JACC Cardiovasc. Imaging 4 (2011) 1274-1283.
23. N.R. Ghugre, V. Ramanan, M. Pop, Y. Yang, J. Barry, B. Qiang, K.A. Connelly, A.J. Dick, G.A. Wright, Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI, Magn. Reson. Med. 66 (2011) 1129-1141.
24. T. Reffelmann, R.A. Kloner, The "no-reflow" phenomenon: basic science and clinical correlates, Heart 87 (2002) 162-168.
25. S.V. Pislaru, L. Barrios, T. Stassen, L. Jun, C. Pislaru, F. Van de Werf, Infarct size, myocardial hemorrhage, and recovery of function after mechanical versus pharmacological reperfusion: effects of lytic state and occlusion time, Circulation 96 (1997) 659-666.
26. D.T. Wong, M.C. Leung, R. Das, R. Puri, G.Y. Liew, K.S. Teo, D.P. Chew, I.T. Meredith, M.I. Worthley, S.G. Worthley, Intracoronary ECG ST-segment recovery during primary percutaneous intervention for ST-segment myocardial infarction: insights from a cardiac MRI study, Catheter. Cardiovasc. Interv. 80 (2012) 746-753.
27. C.K. Wong, P. Herbison, Initial Q waves and outcome after reperfusion therapy in patients with ST elevation acute myocardial infarction: a systematic review, Int. J. Cardiol. 148 (2011) 305-308.
28. M.H. Bao, Y. Zheng, C.M. Westerhout, Y. Fu, G.S. Wagner, B. Chaitman, C.B. Granger, P.W. Armstrong, Prognostic implications of quantitative evaluation of baseline Q-wave width in ST-segment elevation myocardial infarction, J. Electrocardiol. 47 (2014) 465-471.
29. J.S. Hochman, G.A. Lamas, C.E. Buller, et al., Coronary intervention for persistent occlusion after myocardial infarction, N. Engl. J. Med. 355 (2006) 2395-2407.
30. C.K. Wong, W. Gao, O.C. Raffel, J.K. French, R.A. Stewart, H.D. White, Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patient given streptokinase therapy: an analysis from HERO-2, Lancet 367 (2006) 2061-2067.
31. C.K. Wong, iPhone ECG monitoring - the gateway to the new paradigm of STEMI therapy, Int. J. Cardiol. 168 (2013) 2897-2898.
32. C.K. Wong, Acceptable transfer delay to primary PCI versus on-site fibrinolysis for STEMI - can ECG parameters help clinical judgment? Int. J. Cardiol. 167 (2013) 2366-2368.
33. C.K. Wong, H.D. White, The HERO-2 ECG sub-studies in patients with ST elevation myocardial infarction: implications for clinical practice, Int. J. Cardiol. 170 (2013) 17-23.
34. C.K. Wong, Minimizing false activation of cath lab for STEMI - a realistic goal? Int. J. Cardiol. 172 (2014) e91-e93.
35. N. Danchin, E. Puymirat, P.G. Steg, P. Goldstein, F. Schiele, L. Belle, Y. Cottin, J. Fajadet, K. Khalife, P. Coste, J. Ferrières, T. Simon, FAST-MI 2005 Investigators, Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort, Circulation 129 (2014) 1629-1636.
36. C.K. Wong, Acute STEMI care in the 2010s: what has the STREAM trial shown in reperfusing early cases and what should the next breakthrough be? Int. J. Cardiol. 168 (2013) 4305-4306.
37. C.K. Wong, Aborting STEMI: what treatment opportunities may smart-phone ECGs give us prior to first medical contact to facilitate primary PCI? Int. J. Cardiol. 168 (2013) 5453-5455.
38. J.G. Canto, M.G. Shlipak, W.J. Rogers, J.A. Malmgren, P.D. Frederick, C.T. Lambrew, J.P. Ornato, H.V. Barron, C.I. Kiefe, Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain, JAMA 283 (2000) 3223-3229.
39. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, D.E. Casey Jr., M.K. Chung, J.A. de Lemos, S.M. Ettinger, J.C. Fang, F.M. Fesmire, B.A. Franklin, C.B. Granger, H.M. Krumholz, J.A. Linderbaum, D.A. Morrow, L.K. Newby, J.P. Ornato, N. Ou, M.J. Radford, J.E. Tamis-Holland, C.L. Tommaso, C.M. Tracy, Y.J. Woo, D.X. Zhao, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J. Am. Coll. Cardiol. 61 (2013) e78-e140.
40. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), P.G. Steg, S.K. James, D. Atar, L.P. Badano, C. Blömstrom-Lundqvist, M.A. Borger, C. Di Mario, K. Dickstein, G. Ducrocq, F. Fernandez-Aviles, A.H. Gershlick, P. Giannuzzi, S. Halvorsen, K. Huber, P. Juni, A. Kastrati, J. Knuuti, M.J. Lenzen, K.W. Mahaffey, M. Valgimigli, A. van't Hof, P. Widimsky, D. Zahger, ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur. Heart J. 33 (2012) 2569-2619.
41. J.S. Hochman, L.A. Sleeper, J.G. Webb, T.A. Sanborn, H.D. White, J.D. Talley, C.E. Buller, A.K. Jacobs, J.N. Slater, J. Col, S.M. McKinlay, T.H. LeJemtel, Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock, N. Engl. J. Med. 341 (1999) 625-634.
42. J.G. Webb, A.M. Lowe, T.A. Sanborn, H.D.White, L.A. Sleeper, R.G. Carere, C.E. Buller, S.C. Wong, J. Boland, V. Dzavik, M. Porway, G. Pate, G. Bergman, J.S. Hochman, SHOCK Investigators, Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial, J. Am. Coll. Cardiol. 42 (2003) 1380-1386.
43. J.G. Webb, T.A. Sanborn, L.A. Sleeper, R.G. Carere, C.E. Buller, J.N. Slater, K.W. Baran, P.T. Koller, J.D. Talley, M. Porway, J.S. Hochman, SHOCK Investigators, Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry, Am. Heart J. 141 (2001) 964-970.
44. J.S. Hochman, L.A. Sleeper, H.D. White, V. Dzavik, S.C. Wong, V. Menon, J.G. Webb, R. Steingart, M.H. Picard, M.A. Menegus, J. Boland, T. Sanborn, C.E. Buller, S. Modur, R. Forman, P. Desvigne-Nickens, A.K. Jacobs, J.N. Slater, T.H. LeJemtel, SHOCK Investigators, Should we emergently revascularize occluded coronaries for cardiogenic shock. One-year survival following early revascularization for cardiogenic shock, JAMA 285 (2001) 190-192.